Molecular Mechanisms and Clinical Implications of Pancreatic Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (1 September 2024) | Viewed by 432
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pancreatic cancer is one of the most lethal malignancies. Despite significant progress in other cancers, pancreatic cancer survival rates have remained relatively unchanged for 40 years. Therefore, new approaches are critical to successfully diagnosing and treating this disease.
Due to the recent progress in comprehensive analysis using next-generation sequencing, we have deeply understood the molecular characteristics of pancreatic cancer, including genetic and epigenetic alterations. These alterations are potent biomarkers for diagnosis and predicting therapeutic outcomes for pancreatic cancer patients. The real-time monitoring of these alterations is realized by the use of liquid biopsy and has been implemented into clinical practice.
This Special Issue focuses on the potent biomarkers underlying the molecular biology of pancreatic cancer and discusses how to implicate them into clinical practice. Original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: Molecular Mechanisms and Clinical Implications of Pancreatic Cancer.
We look forward to receiving your contributions.
Dr. Koichi Suzuki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- diagnose, treatments
- potent biomarkers
- molecular biology
- clinical implications
- therapeutic outcome
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
